STEPHANIE SABATER-GEIB: Open Payments
NPI 1053754168 · PORTAGE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 51 payments from 15 companies in 2025. Trend: 2023 $497 · 2024 $936 · 2025 $1,096
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $321 |
| Janssen Biotech, Inc. | 9 | $179 |
| GENZYME CORPORATION | 6 | $150 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $64 |
| Novartis Pharmaceuticals Corporation | 4 | $62 |
| Lilly USA, LLC | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Incyte Corporation | 2 | $47 |
| UCB, Inc. | 1 | $35 |
| Amgen Inc. | 2 | $35 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, RINVOQ, ILUMYA, COSENTYX, TALTZ, OPZELURA.
Industry payments across MI — which companies pay providers there.
